INTRODUCTION Endoscopic transenteric stenting is the standard treatment for pseudocysts, but it may be inadequate for treating infected collections with solid debris. Surgical necrosectomy results in significant morbidity. Direct endoscopic necrosectomy (DEN), a minimally invasive treatment, may be a viable option. This study examined the efficacy and safety of DEN for the treatment of infected walled-off pancreatic necrosis and infected pseudocysts with solid debris.
INTRODUCTION
Endoscopic ultrasonography (EUS)-guided transenteric stenting is now regarded as the technique of choice for the drainage of symptomatic pancreatic pseudocyst (PC) due to its lower morbidity as compared to surgical and percutaneous drainage, as well as an efficacy similar to that of surgery. (1) (2) (3) In the context of infected pancreatic fluid collections with solid debris, inserting transenteric stents alone may be inadequate, as the infected solid debris may require physical removal. In fact, comparative studies have shown that unlike for PC, where the clinical success rate of endoscopic drainage ranged from over 90% to nearly 100%, transenteric drainage alone for infected walled-off pancreatic necrosis (WOPN) had a much lower success rate of 25%-45%. (4, 5) Surgical necrosectomy for these patients may result in significant morbidity.
Direct endoscopic necrosectomy (DEN) is a minimally invasive treatment option that has been introduced in recent years for the treatment of infected WOPN. (6, 7) Infected WOPN are pancreatic collections that arise as a complication of severe necrotising pancreatitis, where liquefactive necrosis occurs, and in which a pseudo-capsule or wall subsequently develops. With the technique of DEN, a stoma is created endoscopically between the enteric lumen and the walled-off fluid collection to allow the insertion of an endoscope directly into the fluid collection, which allows endoscopic necrosectomy to be performed.
This Singapore study presents our initial experience of DEN via a transgastric approach for the treatment of infected WOPN and infected PC with solid debris, and examines its efficacy and safety.
METHODS
This study was conducted at the Department of Gastroenterology, Changi General Hospital, Singapore. It was a retrospective analysis of data collected from a prospective database set up when endoscopic drainage of walled-off pancreatic collections was offered as part of the hospital's clinical service in November The definitions of pancreatic fluid collections were based on the revised Atlanta classification by the Acute Pancreatitis Classification Working Group, and are described as follows: (8) ( DEN was performed as a staged procedure using a transgastric approach for all patients due to the proximity of the collection to the gastric wall. EUS-guided transgastric stenting was performed at the first session for initial drainage and to establish endoscopic access to the infected collection. This was similar to standard transgastric stenting for PC drainage. Prior to drainage, all patients were already receiving intravenous carbapenem for treatment. Under conscious sedation using a combination of intravenous midazolam and fentanyl, a linear echoendoscope was used to visualise the infected collection across the gastric wall. Under Doppler ultrasonographic-guidance, the collection was punctured using a 19G needle (EUSN-19-T; Cook Endoscopy, Winston-Salem, NC, USA) ( Fig. 1 ) and a 0.035" guidewire was inserted through the needle into the collection under fluoroscopic guidance (Fig. 2) . The puncture tract was sequentially dilated to 8-10 mm using a Soehendra dilator (Cook Endoscopy) and balloon dilators (CRE TM , Boston Scientific, Natick, MA, USA). Two double pigtail stents (both were 10 Fr in diameter, or one was 10 Fr while the other was 8.5 Fr) were then inserted for transgastric drainage of the infected collection (Fig. 3) . The two stents were inserted either sequentially via repeated cannulation of the cavity under fluoroscopy or using a double wire technique.
(1,9)
The second session was performed after 24-48 hours.
Endoscopy was repeated under conscious sedation. The cystogastrostoma was recannulated, a guidewire inserted into the collection and a balloon catheter (CRE TM ) used to dilate the stoma endoscopically up to 15 mm. A standard gastroscope was then inserted into the cavity (Fig. 4a ). Saline irrigation, suctioning and debridement of the necrotic material using Dormia baskets ( This delay will allow the encapsulation and demarcation of the infected necrotic collections. Demarcation facilitates necrosectomy and reduces complications related to drainage and debridement procedures. (10, 11) Although definitive, surgical drainage and necrosectomy may result in a prolonged recovery period, the need for repeated interventions, as well as the occurence of external fistulae and abdominal wall hernias. (12, 13) For instance, a recent multicentre randomised controlled study (14) randomly assigned 88 patients with necrotising pancreatitis and suspected or confirmed infected necrotic tissue to undergo either primary open necrosectomy or a step-up approach as treatment.
The step-up approach consisted of percutaneous drainage, only three large non-comparative case series have been published on DEN so far. These include a German multicentre study (n = 93), (19) a US multicentre study (n = 104) (20) and a large singlecentre case series (n = 80) from the centre that initially pioneered this technique. (21) According to these reports, high clinical success rates of 80%-91% could be achieved using DEN. In the German study, the complication and 30-day mortality rates were 26% and 7.5%, respectively. (19) In the US study, complications occurred in 14% of patients and included 5 (4.8%) cases of retrogastric perforations/pneumoperitoneum that were managed nonoperatively. (20) There is a lack of comparative studies between DEN and surgical necrosectomy. To the authors' knowledge, to date, only one published randomised study has compared DEN with surgical necrosectomy. In a recent Dutch multicentre randomised controlled study, (22) patients with signs of infected necrotising pancreatitis were randomly assigned to undergo endoscopic 
Although comparative data between DEN and surgery are lacking, the results of surgical series provide some insight into the relative merits of DEN. The outcomes of surgical necrosectomy have recently been reviewed. (15, 23) Retroperitoneal necrosectomy was associated with an average major complication rate of 41%
(range 0%-43%) and a mortality rate of 16% (range 0%-27.3%).
Meanwhile, laparoscopic necrosectomy was associated with major complication rates of 0%-50% and a mean mortality rate of 7% (range 0%-10.5%). However, it must be qualified that the sample size of these individual surgical series was small were managed non-surgically. (20) However, it should be noted that should severe bleeding due to vascular laceration occur, salvage surgery would be required for haemostasis. In our case series, no complications were encountered.
Percutaneous drainage using large-bore catheters has been used by interventional radiologists to manage symptomatic PC. Apart from considering the need and choice of drainage techniques to address the possibility of recurrent pancreatic fluid collections, the pancreatic duct anatomy must also be assessed as part of a holistic treatment strategy. Fluid collections would recur in the presence of persistent pancreatic duct disruption or disconnected pancreatic duct syndrome. (25) Endoscopic treatment by stenting across the duct disruption may facilitate healing and prevent recurrence. (26) When fistulas persist despite prolonged stenting, it is possible to seal the fistula endoscopically using cyanoacrylate. (27, 28) When there is complete disruption of the pancreatic duct, as seen in patients with disconnected pancreatic duct syndrome, it may be technically difficult to bridge the disruption endoscopically; such a situation will predispose the patient to recurrent fluid collections. Even when successful, the effect of endoscopic therapy may only be temporary and surgery might still be required. A randomised trial suggested that long-term transenteric stenting in patients with disconnected pancreatic duct syndrome may be an alternative to surgery to prevent the recurrence of collection. (29) However, more data would be required to confirm this finding, given the concerns regarding stent occlusion and infection.
This study was not without its limitations. This was a small, retrospective, single-centre case series that did not compare the outcomes against that of an alternative treatment modality.
Nonetheless, the results of our study are noteworthy, as the technique of DEN is currently only available in limited referral centres globally, with limited published data from Europe and the USA. In our study, the technical and clinical success rates were 100% and 87.5%, respectively. No major complications were encountered in our patients, which was consistent with current published data.
Current data suggest that DEN has the potential to be a less or CMT will depend on multiple factors, including the expertise available at a given centre, specific patient characteristics and risk assessment findings.
